Title: The oral microbiome in clinical practice: Understanding dysbiosis and the case for integrative assessment
Abstract:
The oral cavity harbours one of the most complex and diverse microbial ecosystems in the human body, comprising over 700 bacterial species alongside fungi, viruses, and archaea. Far from being an isolated environment, the oral microbiome is now understood to be a dynamic regulator of both local and systemic health and its clinical significance is increasingly difficult to ignore. Traditional dental assessment remains largely reactive, detecting disease after structural damage has already occurred. Advances in metagenomic sequencing now make it possible to characterise the microbial communities driving that damage long before clinical signs appear. Understanding the balance between pathogenic and commensal species - including cariogenic bacteria such as Streptococcus mutans, periodontal pathogens of the Red Complex (Porphyromonas gingivalis, Treponema denticola, Tannerella forsythia), and protective commensals offers clinicians a fundamentally new lens through which to assess oral health risk and guide preventative care. The implications extend well beyond the mouth. The oral cavity is the primary seeding site for the gut microbiome, and chronic oral dysbiosis has been linked to a range of serious systemic conditions. P. gingivalis and Fusobacterium nucleatum can translocate into the bloodstream via inflamed gingival tissue, driving systemic inflammation associated with cardiovascular disease and atherosclerosis. Oral dysbiosis has been independently associated with insulin resistance in type 2 diabetes, and P. gingivalis has been detected in the brain tissue of Alzheimer's patients. These associations position the oral microbiome not as a niche concern, but as a central pillar of integrative healthcare.
For clinicians working across dentistry, functional medicine, and integrative health, this creates both an opportunity and a responsibility. Microbiome-informed assessment enables earlier identification of at-risk patients, more targeted treatment planning, and the ability to monitor the impact of interventions dietary, pharmacological, or procedural on microbial community structure over time. It also supports a more meaningful conversation with patients about the relationship between their oral health and their wider wellbeing. This presentation will explore the current evidence base for oral microbiome science, examine the clinical conditions most strongly associated with oral dysbiosis, and discuss practical frameworks for incorporating microbiome data into clinical decision-making. The goal is to equip practitioners with a clearer understanding of what the oral microbiome can tell us - and how that knowledge can be translated into better outcomes for patients.
